FDA Import Refusal BSF-0022251-1/2/1 — Glaxo Wellcome Production

Glaxo Wellcome Production — FEI 3010506696

The FDA refused shipment BSF-0022251-1/2/1 from Glaxo Wellcome Production (France) on Dec 9, 2013. The refused product falls under Drugs and Biologics — FLUTICASONE PROPIONATE (BRONCHODILATOR). Cited charge: 179 This firm has 4 other import refusals on record.

Refusal details

Date
Dec 9, 2013
Country
France
Product Category
Drugs and Biologics
Product Code
63BIY25 FLUTICASONE PROPIONATE (BRONCHODILATOR)
Charges
179

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.